We are live on ! Find out more
SEM

Select Medical

Delisted

SEM was delisted on the 30th of June, 2026.

164 hedge funds and large institutions have $1.44B invested in Select Medical in 2017 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 63 increasing their positions, 53 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 20

19% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 53

5% more funds holding

Funds holding: 156164 (+8)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

2% less capital invested

Capital invested by funds: $1.46B → $1.44B (-$28.5M)

4.57% less ownership

Funds ownership: 154.94%150.37% (-4.6%)

Holders
164
Holders Change
+8
Holders Change %
+5.13%
% of All Funds
4.08%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
34
Increased
63
Reduced
53
Closed
20
Calls
$64K
Puts
Net Calls
+$64K
Net Calls Change
+$122K
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$249M +$5.3M +731,097 +2%
BlackRock
2
BlackRock
New York
$182M +$183M +25,230,279 +49,225%
Vanguard Group
3
Vanguard Group
Pennsylvania
$128M +$7.11M +981,382 +6%
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$108M +$11.3M +1,555,556 +12%
NTC
5
North Tide Capital
Massachusetts
$76.1M -$57.9M -7,980,800 -43%
CCM
6
Camber Capital Management
Massachusetts
$66.8M -$13.8M -1,902,400 -17%
Fisher Asset Management
7
Fisher Asset Management
Washington
$62.1M -$1.5M -206,714 -2%
Invesco
8
Invesco
Georgia
$46.8M -$1.08M -148,396 -2%
JP
9
Jana Partners
New York
$39.6M +$9.33M +1,287,286 +31%
State Street
10
State Street
Massachusetts
$37.2M +$2.34M +323,429 +7%
LSV Asset Management
11
LSV Asset Management
Illinois
$30.1M -$28.7M -3,956,082 -49%
O
12
OrbiMed
New York
$27.9M +$16.9M +2,328,167 +151%
Northern Trust
13
Northern Trust
Illinois
$27.1M +$1.44M +198,371 +6%
Norges Bank
14
Norges Bank
Norway
$23.3M +$7M +965,430 +43%
Boston Partners
15
Boston Partners
Massachusetts
$20.8M -$148K -20,457 -0.7%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$20.1M +$1.62M +222,989 +9%
VOYA Investment Management
17
VOYA Investment Management
Georgia
$19.8M +$38.9K +5,360 +0.2%
Prudential Financial
18
Prudential Financial
New Jersey
$19.1M +$5.61M +773,990 +41%
Victory Capital Management
19
Victory Capital Management
Texas
$16.6M +$1M +138,097 +6%
BCM
20
Brigade Capital Management
New York
$16.4M +$5.45M +751,680 +49%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$13.4M +$1.53M +210,912 +13%
Charles Schwab
22
Charles Schwab
California
$11.8M +$1.04M +143,402 +10%
Principal Financial Group
23
Principal Financial Group
Iowa
$11.5M +$399K +55,014 +4%
FP
24
Foundry Partners
Minnesota
$10.1M +$1.23M +170,212 +14%
SGCIA
25
Smith Graham & Co Investment Advisors
Texas
$9.55M -$182K -25,167 -2%

SEM Hedge Fund Activity: Q1 2017 in Review

164 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Select Medical (SEM) for Q1 2017, worth a combined $1.44B — down 1.9% from $1.46B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new SEM positions and 20 closed out — a net gain of 14 holders — while 63 added to existing stakes and 53 trimmed.

The largest buyer was BlackRock, adding an estimated $183M. The largest seller was North Tide Capital, cutting an estimated $57.9M.

  • 164 institutional investors held Select Medical (SEM) as of Q1 2017, up from 156 in Q4 2016.
  • Funds reported $1.44B of Select Medical stock for Q1 2017, down 1.9% quarter-over-quarter.
  • 34 funds opened new Select Medical positions in Q1 2017 and 20 closed out, a net change of +14 holders.
  • The largest Select Medical buyer in Q1 2017 was BlackRock, an estimated $183M added.
  • The largest Select Medical seller in Q1 2017 was North Tide Capital, an estimated $57.9M sold.

Based on aggregated 13F filings for Q1 2017.